Chuck Royce's LMAT Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 3,582 shares of LeMaitre Vascular, Inc. (LMAT) worth $391,047, representing 0.00% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 28 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in LMAT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2018, adding 39,683 shares. Largest reduction occurred in Q1 2019, reducing 75,876 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's LeMaitre Vascular (LMAT) Holding Value Over Time
Track share changes against reported price movement
Quarterly LeMaitre Vascular (LMAT) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +3,582 | New Buy | 3,582 | $109.17 |
| Q1 2024 | -9,200 | Sold Out | 0 | $0.00 |
| Q4 2023 | +9,200 | New Buy | 9,200 | $56.76 |
| Q4 2022 | -5,134 | Sold Out | 0 | $0.00 |
| Q3 2022 | -3,737 | Reduce 42.13% | 5,134 | $50.64 |
| Q2 2022 | +114 | Add 1.30% | 8,871 | $45.54 |
| Q1 2022 | +8,757 | New Buy | 8,757 | $46.48 |
| Q2 2021 | -14,620 | Sold Out | 0 | $0.00 |
| Q1 2021 | -5,020 | Reduce 25.56% | 14,620 | $48.77 |
| Q4 2020 | +4,216 | Add 27.33% | 19,640 | $40.48 |
| Q3 2020 | +5,368 | Add 53.38% | 15,424 | $32.55 |
| Q2 2020 | +4,027 | Add 66.79% | 10,056 | $26.35 |
| Q1 2020 | +83 | Add 1.40% | 6,029 | $24.88 |
| Q4 2019 | -64 | Reduce 1.06% | 5,946 | $35.99 |
| Q3 2019 | +199 | Add 3.42% | 6,010 | $34.11 |
| Q2 2019 | +40 | Add 0.69% | 5,811 | $28.05 |
| Q1 2019 | -75,876 | Reduce 92.93% | 5,771 | $31.02 |
| Q4 2018 | +14,009 | Add 20.71% | 81,647 | $23.64 |
| Q3 2018 | -15,736 | Reduce 18.87% | 67,638 | $38.74 |
| Q2 2018 | +39,683 | Add 90.83% | 83,374 | $33.48 |
| Q1 2018 | +38,471 | Add 736.99% | 43,691 | $36.23 |
| Q4 2017 | +51 | Add 0.99% | 5,220 | $31.80 |
| Q3 2017 | +169 | Add 3.38% | 5,169 | $37.34 |
| Q2 2017 | +5,000 | New Buy | 5,000 | $31.20 |
| Q4 2015 | -9,900 | Sold Out | 0 | $0.00 |
| Q1 2015 | +9,900 | New Buy | 9,900 | $8.38 |
Chuck Royce's LeMaitre Vascular Investment FAQs
Chuck Royce first purchased LeMaitre Vascular, Inc. (LMAT) in Q1 2015, acquiring 9,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held LeMaitre Vascular, Inc. (LMAT) for 28 quarters since Q1 2015.
Chuck Royce's largest addition to LeMaitre Vascular, Inc. (LMAT) was in Q2 2018, adding 83,374 shares worth $2.79 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 3,582 shares of LeMaitre Vascular, Inc. (LMAT), valued at approximately $391,047.
As of the Q1 2026 filing, LeMaitre Vascular, Inc. (LMAT) represents approximately 0.00% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in LeMaitre Vascular, Inc. (LMAT) was 83,374 shares, as reported at the end of Q2 2018.